Between-Strain Competition in Acquisition and Clearance of Pneumococcal Carriage—Epidemiologic Evidence From a Longitudinal Study of Day-Care Children

por Auranen, Kari, Mehtälä, Juha, Tanskanen, Antti, S. Kaltoft, Margit
Publicado 2010

A Pneumococcal Carriage Study in Danish Pre-school Children before the Introduction of Pneumococcal Conjugate Vaccination

por Harboe, Zitta B, Slotved, Hans-Christian, Konradsen, Helle B, Kaltoft, Margit S
Publicado 2012

Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis

por Wilke, Thomas, Mueller, Sabrina, Fuchs, Andreas, Kaltoft, Margit S., Kipper, Stefan, Cel, Malgorzata
Publicado 2020

Efficacy of liraglutide added to sodium‐glucose cotransporter‐2 inhibitors in type 2 diabetes, stratified by baseline characteristics: Post‐hoc analysis of LIRA‐ADD2SGLT2i

por Blonde, Lawrence, Fainberg, Udi, Kaltoft, Margit S., Mosenzon, Ofri, Ramesh, Chethana, Rea, Rosangela
Publicado 2021

Effect of once‐weekly semaglutide versus thrice‐daily insulin aspart, both as add‐on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUS...

por Kellerer, Monika, Kaltoft, Margit Staum, Lawson, Jack, Nielsen, Lasse Lykke, Strojek, Krzysztof, Tabak, Ömür, Jacob, Stephan
Publicado 2022

Is there an association between liraglutide use and female breast cancer in a real-world setting?

por Funch, Donnie, Mortimer, Kathleen, Li, Ling, Norman, Heather, Major-Pedersen, Atheline, Olsen, Anne Helene, Kaltoft, Margit S, Dore, David D
Publicado 2018

OR22-1 Liraglutide as Add-on to SGLT2 Inhibitors in Patients with Inadequately Controlled Type 2 Diabetes (LIRA-ADD2SGLT2i): A 26-Week, Randomized, Double-Blind, Placebo-Controlled...

por Blonde, Lawrence, Belousova, Lidia, Fainberg, Udi, Garcia-Hernandez, Pedro, Jain, Sunil, Kaltoft, Margit, Mosenzon, Ofri, Nafach, Jalal, Palle, Mads, Réa, Rosangela
Publicado 2019

Liraglutide as add‐on to sodium‐glucose co‐transporter‐2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA‐ADD2SGLT2i, a 26‐week, randomized, double‐blind,...

por Blonde, Lawrence, Belousova, Lidia, Fainberg, Udi, Garcia‐Hernandez, Pedro A., Jain, Sunil M., Kaltoft, Margit S., Mosenzon, Ofri, Nafach, Jalal, Palle, Mads Sundby, Rea, Rosangela
Publicado 2020

Trial design and baseline data for LIRA‐PRIME: A randomized trial investigating the efficacy of liraglutide in controlling glycaemia in type 2 diabetes in a primary care setting

por Unger, Jeff, Allison, Dale C., Carlton, Melissa, Lakkole, Kavitha, Lowe, Derek, Murphy, Gerri, Panda, Jayant K., Sargin, Mehmet, Kaltoft, Margit, Treppendahl, Marianne B., Zoghbi, Marouan
Publicado 2019

Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add‐on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomize...

por Unger, Jeff, Allison, Dale C., Kaltoft, Margit, Lakkole, Kavitha, Panda, Jayant K., Ramesh, Chethana, Sargin, Mehmet, Smolyarchuk, Elena, Twine, Melissa, Wolthers, Benjamin, Yarimbas, Gizem, Zoghbi, Marouan
Publicado 2021

CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries

por Mosenzon, Ofri, Alguwaihes, Abdullah, Leon, Jose Luis Arenas, Bayram, Fahri, Darmon, Patrice, Davis, Timothy M. E., Dieuzeide, Guillermo, Eriksen, Kirsten T., Hong, Tianpei, Kaltoft, Margit S., Lengyel, Csaba, Rhee, Nicolai A., Russo, Giuseppina T., Shirabe, Shinichiro, Urbancova, Katerina, Vencio, Sergio
Publicado 2021

Genetic Analysis of the Capsular Biosynthetic Locus from All 90 Pneumococcal Serotypes

por Bentley, Stephen D, Aanensen, David M, Mavroidi, Angeliki, Saunders, David, Rabbinowitsch, Ester, Collins, Matthew, Donohoe, Kathy, Harris, David, Murphy, Lee, Quail, Michael A, Samuel, Gabby, Skovsted, Ian C, Kaltoft, Margit Staum, Barrell, Bart, Reeves, Peter R, Parkhill, Julian, Spratt, Brian G
Publicado 2006